Treatment of Anemia with Darbepoetin Alfa Administered de novo Once Every Other Week in Chronic Kidney Disease

Publisher： Karger

E-ISSN： 1421-9670|23|2|106-111

ISSN： 0250-8095

Source： American Journal of Nephrology, Vol.23, Iss.2, 2003-01, pp. : 106-111

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Darbepoetin Alfa Effectively Treats Anemia in Patients with Chronic Kidney Disease with de novo Every-Other-Week Administration

By  

American Journal of Nephrology, Vol. 24, Iss. 4, 2004-09 ,pp. : 453-460

Karger

Access to resources Recommend Favorite

Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients

By  

American Journal of Nephrology, Vol. 45, Iss. 3, 2017-01 ,pp. : 187-199

Karger

Access to resources Recommend Favorite

Low-Dose Treatment with Erythropoiesis-Stimulating Agents and Cardiovascular Geometry in Chronic Kidney Disease: Is Darbepoetin-α More Effective than Expected?

By  

Cardiorenal Medicine, Vol. 2, Iss. 1, 2011-12 ,pp. : 18-25

Karger

Access to resources Recommend Favorite

Anemia in Chronic Kidney Disease and Congestive Heart Failure

By  

Blood Purification, Vol. 21, Iss. 1, 2003-01 ,pp. : 124-130

Karger

Access to resources Recommend Favorite

Hepcidin in Anemia and Inflammation in Chronic Kidney Disease

By  

Kidney and Blood Pressure Research, Vol. 30, Iss. 1, 2007-01 ,pp. : 15-30

Karger

Access to resources Recommend Favorite